1. Cancer Committee Meeting May 11, 2015 Cancer Liaison Physician Report Karen Lisa Smith MD MPH

2. 5 year survival for breast cancer patients at Sibley

4. StageEnter0 Year1 Year2 Year3 Year4 Year5 Year5 Year 95% CI Stage 0407100.0 99.898.798.297.495.8-99.0 Stage I650100.099.598.897.796.295.393.7-97.0 Stage II476100.099.497.995.293.592.189.6-94.6 Stage III137100.0 92.691.188.081.674.9-88.3 Stage IV3Insufficient cases (n<30) Unknown61100.096.7 91.586.280.770.5-91.0 All cases for this data set 1,734100.099.598.196.494.893.292.0-94.4

5. 5 year survival for breast cancer patients at all sites in the NCDB

7. StageEnter0 Year1 Year2 Year3 Year4 Year5 Year5 Year 95% CI Stage 0136,242100.099.598.797.796.695.395.2-95.4 Stage I272,101100.099.297.896.094.192.091.9-92.1 Stage II196,351100.098.395.492.088.785.685.4-85.7 Stage III74,610100.095.387.279.673.267.967.5-68.2 Stage IV25,972100.068.551.338.829.623.222.7-23.7 Not Applicabl e 513100.087.775.570.465.762.257.8-66.6 Unknown33,048100.093.388.684.781.178.077.6-78.5 All cases for this data set 738,837100.097.394.291.188.185.485.3-85.5

8. Breast cancer 5 year survival Sibley outcomes comparable to or better than national NCDB outcomes

9. Number of new prostate cancer patients at Sibley in comparison to other DC hospitals

11. Diagnosis Year of Prostate Cancer Diagnosed in 2010,2011,2012 Sibley Memorial Hospital, Washington DC vs. All Types Hospitals in State of District of Columbia All Diagnosed Cases - Data from 7 Hospitals # Diagnosis Year My (N) Oth. (N)My (%)Oth. (%) 1. 2010157119536.6%39.43% 2. 2011165105438.46%34.77% 3. 201210778224.94%25.8% Col. TOTAL 4293031100%

12. Prostate cancer cases at Sibley Numbers are low What can we do to capture more of the regional market?

13. CP3R Measures for Breast Cancer for Sibley compared to all COC Approved Programs (2012)

14. MeasureSibleyAll COC approved programs *Breast Conserving Surgery for Stage 0-250%63% Image or palpation guided core biopsy or FNA to establish diagnosis 85%89% *Tamoxifen or 3 rd generation AI within 1 yar of diagnosis for stage 1B-3 Hormone receptor positive breast cancer 3.4%90% *RT within in year after mastectomy if >=4+ nodes 46.2%87% *RT within one year after BCS for patients < 70 68%91% *Combination chemotherapy considered or given within 120 days of diagnosis if < 70 and hormone receptor negative and stage 1B-3 36%92% * = Sibley rate below mean of COC approved programs

15. Breast CP3R data Sibley scores are low in many areas Likely represents inaccurate data capture and not poor adherence with these standard of care measures How can we improve data capture for these measures?

16. Note: inadequate numbers to meaningfully review CP3R data from 2012 for other sites with measures (gastric, colon, lung, rectum, cervix)

17. Questions?